SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001654954-18-007990
Filing Date
2018-07-24
Accepted
2018-07-24 17:22:54
Documents
59
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 6-K/A form6-k_a.htm 6-K/A 23679
  Complete submission text file 0001654954-18-007990.txt   2731464

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ipci-20180531.xml EX-101.INS 716790
3 XBRL TAXONOMY EXTENSION SCHEMA ipci-20180531.xsd EX-101.SCH 48874
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipci-20180531_cal.xml EX-101.CAL 43965
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipci-20180531_def.xml EX-101.DEF 91376
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipci-20180531_lab.xml EX-101.LAB 256595
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipci-20180531_pre.xml EX-101.PRE 179050
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 6-K/A | Act: 34 | File No.: 000-53805 | Film No.: 18967187
SIC: 2834 Pharmaceutical Preparations